WALTHAM, MA -- (Marketwired) -- 02/10/14 -- Fresenius Medical Care Renal Therapies Group, LLC (RTG), a leading manufacturer of dialysis products, announced today the launch of its Home Hemodialysis (HHD) Concierge Services program, which aids patient transition to HHD using the 2008K@home hemodialysis machine. Patients who are looking for independence and more control of their health care may find that dialysis in the home setting allows them more flexibility to keep up with their active lifestyle. With HHD, patients and their care partner perform dialysis at home after a few weeks of training in the dialysis home training center.
Patients and caretakers may face questions during their transition to HHD because the equipment and procedures are new to them. While clinicians focus on patient and caregiver training and educating, HHD Concierge Service offers expertise and assistance to simplify the HHD start-up process for both patients and dialysis providers. Services include:
HHD Concierge Services aims to streamline the transition to home therapies for patients and clinicians, allowing them to leave the details to Fresenius Medical Care Renal Therapies Group experts. User-friendly tools such as preparation checklists, initial and follow-up plumbing and electrical support, make home evaluation less intimidating and easy to understand. Home preparation and modification is offered through competitively priced bids via subcontractors that are located through a national contracting service. As part of the program, an HHD Concierge Service representative will also arrange for a Fresenius Medical Care Renal Therapies Group equipment specialist to install the 2008K@home hemodialysis machine and reverse osmosis (RO) system, and sample water that's used for home dialysis treatment.
For information about Fresenius Medical Care Renal Therapies Group, visit www.fmcna.com.
Indications for Use: The Fresenius Medical Care 2008K@home machine is indicated for acute and chronic dialysis therapy in an acute or chronic facility. It is also indicated for hemodialysis in the home and must be observed by a trained and qualified person as prescribed by a physician.
Caution: (US) federal law restricts this device to sale by or on the order of a physician or other licensed practitioner. For safe and proper use of the device refer to the device's Instructions for Use. See full package labeling for a complete description of hazards, contraindications, side effects and precautions available at www.fmcna.com.
About Fresenius Medical Care Renal Therapies Group, LLC
Fresenius Medical Care Renal Therapies Group, LLC (RTG) is North America's top producer of dialysis equipment, dialyzers and related disposable products and a major supplier of renal pharmaceuticals. RTG is a division of Fresenius Medical Care North America, the continent's leading provider of renal care, and designated as Forbes Magazine's World's Most Innovative Companies in 2011, 2012 and 2013. For more information about Renal Therapies Group and Fresenius Medical Care North America, visit www.fmcna.com.